Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jul;29(7):740.
doi: 10.1111/iju.14920. Epub 2022 May 10.

Editorial Comment from Dr Yuasa to Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma

Takeshi Yuasa  1
Affiliations
Editorial

Editorial Comment from Dr Yuasa to Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma

Takeshi Yuasa. Int J Urol. 2022 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None declared.

Comment on

References

    1. Williamson EJ, Walker AJ, Bhaskaran K et al. Factors associated with COVID‐19‐related death using OpenSAFELY. Nature 2020; 584: 430–6. - PMC - PubMed
    1. Fujiwara M, Yuasa T, Komai Y et al. Switching patients with prostate cancer from GnRH antagonist to long‐acting LHRH agonist for androgen deprivation: reducing hospital visits during the coronavirus pandemic. Cancer Diagn. Progn. 2021; 1: 1–5. - PMC - PubMed
    1. Fendler A, de Vries EGE, GeurtsvanKessel CH et al. COVID‐19 vaccines in patients with cancer: immunogenicity, efficacy and safety. Nat. Rev. Clin. Oncol. 2022; 11: 1–17. - PMC - PubMed
    1. Togashi K, Hatakeyama S, Yoneyama T et al. Effect of active anticancer therapy on serologic response to SARS‐CoV‐2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma. Int. J. Urol. 2022; 29: 733–9. - PMC - PubMed
    1. Nasti TH, Eberhardt CS. Vaccination against cancer or infectious agents during checkpoint inhibitor therapy. Vaccines (Basel) 2021; 9: 1396. - PMC - PubMed